Equine infectious anemia virus in China

Area of Science:

• Veterinary Virology
• Equine Infectious Diseases
• Immunology

Background:

• Equine infectious anemia (EIA) is a significant disease affecting horses, first documented in 1840.
• Research into equine infectious anemia virus (EIAV) in China commenced in the 1960s, addressing key aspects like etiology, pathology, diagnosis, and immunology.
• EIAV poses a persistent threat to equine health globally.

Purpose of the Study:

• To provide a comprehensive review of EIAV research in China.
• To highlight significant milestones, including the development of an attenuated vaccine.
• To acknowledge the contributions of scientists in EIAV prevention.

Main Methods:

• Literature review of historical and contemporary research on EIAV in China.
• Analysis of key findings in etiology, pathology, diagnosis, and immunology.
• Examination of vaccine development and efficacy data.

Main Results:

• Significant progress in understanding EIAV, its transmission, and pathogenesis.
• Successful development and deployment of an attenuated EIAV vaccine in 1978, leading to disease control.
• Ongoing research focusing on advanced diagnostic tools and novel prevention strategies.

Conclusions:

• China has made substantial contributions to controlling equine infectious anemia through dedicated research and vaccine development.
• The 1978 attenuated vaccine remains a cornerstone in EIAV prevention efforts in the region.
• Continued research and scientific collaboration are crucial for the future eradication of EIAV.